Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2016 12:31 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech CEO Interviewed by Small Cap Nation

SILVER SPRING, Md., June 28, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
June 23, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Releases Medical and Scientific Discussion from 2016 ASCO Annual Meeting

SILVER SPRING, Md., June 23, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
June 20, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech CEO Interviewed Live During Marcum MicroCap Conference

SILVER SPRING, Md., June 20, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
June 07, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Present Cancer and Diabetes Therapies at 2016 BIO International Convention

SILVER SPRING, Md., June 07, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
June 03, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Officers to Attend Annual Meeting of the American Society of Clinical Oncology

SILVER SPRING, Md., June 03, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
May 31, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s CEO Featured Speaker at Marcum MicroCap Conference

SILVER SPRING, Md., May 31, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
May 26, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences

SILVER SPRING, Md., May 26, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
May 24, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Engage Principal Investigator for Clinical Trial in Pancreatic Cancer

SILVER SPRING, Md., May 24, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
May 12, 2016 09:33 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Receives ‘Notice of Allowance’ for Patent Protection of the Melligen Cells to Treat Diabetes

SILVER SPRING, Md., May 12, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
May 03, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Appoints Former Johnson & Johnson Executive as Senior Business Development Advisor

SILVER SPRING, Md., May 03, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...